Table 1. Limiting-dilution analysis of HVR diversity during acute infection.
Patient | Age/sex | Presentingsymptoms | Peak ALT(U l−1) | Recent travel history | Virus genotype | No. ofsequencesobtained | Variablesites* | Meandiversity(%)† | Syn‡ | Nsyn‡ |
2 | 29/M | Jaundice, fever | Indiansubcontinent | 1 | 21 | 1 | 0.08 | 1 | 0 | |
7 | 55/F | Jaundice | 2989 | Spain | 3 | 5 | 0 | 0 | 0 | 0 |
101 | 62/M | Jaundice | 2881 | None | 3 | 6 | 0 | 0 | 0 | 0 |
102 | 58/M | Jaundice | 2245 | None | 3 | 20 | 4 | 0.20 | 2 | 2 |
103 | 40/M | Jaundice | 6185 | Spain | 3 | 28 | 0 | 0 | 0 | 0 |
104 | 25/M | Fulminant hepatitis | 4121 | India | 1 | 22 | 5 | 0.30 | 2 | 3 |
21§ | 55/M | Jaundice | 1993 | None | 3 | 21 | 25 | 2.6 | 19 | 7 |
3 | A: 17 | 3 | 0.14 | 1 | 2 | |||||
3 | B: 4 | 1 | 0.40 | 1 | 0 | |||||
22 | 68/F | Abnormal liver function | 4023 | Spain | 3 | 18 | 1 | 0.20 | 0 | 1 |
No. of variable sites amongst sequence set.
Mean p distance amongst sequence set.
Syn, no. of synonymous substitutions; Nsyn, no. of non-synonymous substitutions.
For patient 21, the diversity amongst the two populations (A and B) of virus sequences detected is also shown separately.